Dave Morin is a Co-Founder and serves as Partner at Slow Ventures. He previously was Co-Founder and Chief Executive Officer and Director at Path. Morin was a Senior Platform Manager at Facebook and a Mentor at TechStars. Morin is a visionary entrepreneur, technologist, and businessman. Previously, he held positions at Apple, including a Manager of Creation and Collaboration and a Manager of Student Marketing. Morin also founded a design focused technology and internet software company called DM Design Studios in college. He has appeared in publications such as The Economist, Wired, CNN, BusinessWeek, Money, Business 2.0, TechCrunch, CNET, Silicon Alley Insider, The Los Angeles Times, Chicago Tribune, The San Francisco Chronicle, VentureBeat, and others. Morin is a passionate and well received speaker and has delivered keynotes and participated in events worldwide such as South by Southwest, Future of Web Apps, Web 2.0 Expo, Le Web, SNAP Summit, Microsoft MIX, O'Reilly Foo Camp, Facebook f8, and the worldwide syndicate of Facebook Developer Garages. His focus on innovation, vision, and technology strategy has involved extensive interaction with the global market at large. He also serves as a Board Member at Eventbrite and Dwell Media. Morin received a degree in Economics and Business Administration from the University of Colorado at Boulder.
How to connect with Angel Investors in the Pharmaceutical industry?
In the Pharmaceutical & Medicine industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are prominent figures. These investors focus on startups offering innovative solutions in drug development, biotechnology, and medical research. Esther Dyson, an entrepreneur and investor, invests in pharmaceutical startups that leverage technology to advance medical research and improve patient outcomes. Vinod Khosla, founder of Khosla Ventures, looks for companies that provide groundbreaking pharmaceutical solutions and therapies. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with strong scientific foundations and significant market potential. To connect with these investors, attend pharmaceutical conferences, biotech expos, and networking events such as BIO International Convention, JP Morgan Healthcare Conference, and CPhI Worldwide. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your pharmaceutical solution addresses key challenges, such as improving drug efficacy, enhancing patient care, or advancing medical research. Highlight any traction you’ve gained, such as partnerships with research institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as drug sales, licensing, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from pharmaceutical experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
